• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Clinical trials of agents that reverse multidrug-resistance.

作者信息

Gottesman M M, Pastan I

机构信息

National Cancer Institute Bethesda, MD.

出版信息

J Clin Oncol. 1989 Apr;7(4):409-11. doi: 10.1200/JCO.1989.7.4.409.

DOI:10.1200/JCO.1989.7.4.409
PMID:2564427
Abstract
摘要

相似文献

1
Clinical trials of agents that reverse multidrug-resistance.逆转多药耐药性药物的临床试验。
J Clin Oncol. 1989 Apr;7(4):409-11. doi: 10.1200/JCO.1989.7.4.409.
2
Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy.多发性骨髓瘤和非霍奇金淋巴瘤中的耐药性：P-糖蛋白的检测以及通过在化疗中添加维拉帕米来潜在规避耐药性
J Clin Oncol. 1989 Apr;7(4):415-24. doi: 10.1200/JCO.1989.7.4.415.
3
The role of P-glycoprotein in drug-resistant hematologic malignancies.
Cancer Treat Res. 1991;57:187-208. doi: 10.1007/978-1-4615-3872-1_9.
4
Antitumor activity of the new vinca-alkaloid S 12363 alone or in combination with verapamil on a human multidrug resistant renal carcinoma xenograft.
In Vivo. 1993 Sep-Oct;7(5):399-405.
5
[The pleiotropic drug resistance phenotype: role of reverting agents "in vitro" and "in vivo"].[多药耐药表型：“体外”和“体内”回复剂的作用]
Haematologica. 1991 Jun;76 Suppl 3:173-6.
6
Reversal of P-glycoprotein-associated multidrug resistance: the challenge continues.P-糖蛋白相关多药耐药性的逆转：挑战仍在继续。
Eur J Cancer. 1993;29A(4):636-8. doi: 10.1016/s0959-8049(05)80169-8.
7
[Multidrug resistance in hematological malignancies: prognostic significance and the effect of resistance-modulating drugs].[血液系统恶性肿瘤中的多药耐药性：预后意义及耐药性调节药物的作用]
Ned Tijdschr Geneeskd. 1994 Mar 5;138(10):508-12.
8
P-glycoprotein expression and in vitro reversion of doxorubicin resistance by verapamil in clinical specimens from acute leukaemia and myeloma.急性白血病和骨髓瘤临床标本中P-糖蛋白的表达及维拉帕米对阿霉素耐药性的体外逆转作用
Leukemia. 1991 Jul;5(7):592-7.
9
Severe combined immunodeficiency (SCID) mouse modeling of P-glycoprotein chemosensitization in multidrug-resistant human myeloma xenografts.多药耐药人骨髓瘤异种移植中P-糖蛋白化学增敏作用的严重联合免疫缺陷（SCID）小鼠模型
Clin Cancer Res. 1995 Dec;1(12):1563-70.
10
[Tumor resistance to multiple antineoplastic agents mediated by glycoprotein P: from the laboratory to the clinical field].
Med Clin (Barc). 1994 Apr 9;102(13):506-15.

引用本文的文献

1
Quantitative Structure⁻Activity Relationships for the Flavonoid-Mediated Inhibition of P-Glycoprotein in KB/MDR1 Cells.黄酮类化合物介导的 P-糖蛋白在 KB/MDR1 细胞中抑制的定量构效关系。
Molecules. 2019 Apr 27;24(9):1661. doi: 10.3390/molecules24091661.
2
Influence of concurrent medications on outcomes of men with prostate cancer included in the TAX 327 study.TAX 327研究中同时使用的药物对前列腺癌男性患者治疗结果的影响。
Can Urol Assoc J. 2013 Jan-Feb;7(1-2):E74-81. doi: 10.5489/cuaj.267.
3
Effect of dose and dosage interval on the oral bioavailability of docetaxel in combination with a curcumin self-emulsifying drug delivery system (SEDDS).
剂量和给药间隔对多西他赛与姜黄素自乳化药物递送系统（SEDDS）联合应用时口服生物利用度的影响。
Eur J Drug Metab Pharmacokinet. 2012 Sep;37(3):217-24. doi: 10.1007/s13318-011-0078-1. Epub 2011 Dec 27.
4
Carrier-free cellular uptake and the gene-silencing activity of the lipophilic siRNAs is strongly affected by the length of the linker between siRNA and lipophilic group.无载体细胞摄取和疏水性 siRNA 的基因沉默活性强烈受到 siRNA 和疏水性基团之间连接体长度的影响。
Nucleic Acids Res. 2012 Mar;40(5):2330-44. doi: 10.1093/nar/gkr1002. Epub 2011 Nov 10.
5
Enhanced oral bioavailability of paclitaxel by coadministration of the P-glycoprotein inhibitor KR30031.通过联合给予P-糖蛋白抑制剂KR30031提高紫杉醇的口服生物利用度。
Pharm Res. 2003 Jan;20(1):24-30. doi: 10.1023/a:1022286422439.
6
Detection of the multidrug resistance marker P-glycoprotein by immunohistochemistry in malignant lung tumours.通过免疫组织化学检测恶性肺肿瘤中的多药耐药标志物P-糖蛋白
Thorax. 1996 May;51(5):526-9. doi: 10.1136/thx.51.5.526.
7
Targeting chemosensitizing doses of toremifene based on protein binding.基于蛋白结合作用靶向使用托瑞米芬的化疗增敏剂量。
Cancer Chemother Pharmacol. 1993;31(5):412-4. doi: 10.1007/BF00686157.
8
Differential effectiveness of a range of novel drug-resistance modulators, relative to verapamil, in influencing vinblastine or teniposide cytotoxicity in human lymphoblastoid CCRF-CEM sublines expressing classic or atypical multidrug resistance.一系列新型耐药调节剂相对于维拉帕米，在影响表达经典或非典型多药耐药的人淋巴母细胞CCRF-CEM亚系中长春碱或替尼泊苷细胞毒性方面的差异有效性。
Cancer Chemother Pharmacol. 1994;33(4):317-24. doi: 10.1007/BF00685907.
9
Inhibition of P-glycoprotein-mediated vinblastine transport across HCT-8 intestinal carcinoma monolayers by verapamil, cyclosporine A and SDZ PSC 833 in dependence on extracellular pH.维拉帕米、环孢素A和SDZ PSC 833对P-糖蛋白介导的长春碱跨HCT-8肠癌细胞单层转运的抑制作用与细胞外pH的关系
Cancer Chemother Pharmacol. 1994;34(2):125-32. doi: 10.1007/BF00685929.
10
Antibodies in the study of multiple drug resistance.多重耐药性研究中的抗体
Cytotechnology. 1993;12(1-3):91-107. doi: 10.1007/BF00744659.